Loading asset research
BlossomHill Therapeutics Inc. Common Stock
BLSMNasdaq · USD · StocksQuote as of · Exchange session not verified$21.15
-1.67%
Today
BLSM
Loading 1D prices…
Market cap
$606.6M
Volume
148.9K
52w high
$23.3752w low
$15.25Company profile
BlossomHill Therapeutics Inc. Common Stock
BlossomHill Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecule medicines that address medical needs in cancer treatment. Its pipeline includes BH-30643, an OMNI-EGFR inhibitor in clinical development for advanced EGFR-mutant non-small cell lung cancer (NSCLC), BH-501284, and BH-30236, a macrocyclic CLK (Cdc2-like kinase) inhibitor being evaluated in patients with relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndrome (HR-MDS). BlossomHill Therapeutics, Inc. was incorporated in 2020 and is based in San Diego, California.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
San Diego, CA, United States
Employees
63
Fiscal year end
1231
CIK
1839970
Session & valuation
Open$21.55
Previous close$21.51
Day high$21.90
Day low$20.75
30-day avg. volume266.3K
Outstanding shares—
Diluted EPS-$2.08
Latest annual period
P/E (trailing)-10.16
P/E (forward)-5.62
Price / book-0.36
Beta—
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ASMBAssembly Biosciences Inc. Common Stock | $606.7M | $72.3M | -8.47% | -$0.55 | -2.17% | Buy |
| CRMDCorMedix Inc. Common Stock | $609.9M | $311.7M | +52.31% | $2.04 | -1.76% | Buy |
| MPLTMapLight Therapeutics Inc. Common Stock | $602.9M | $0.00 | — | -$18.56 | -5.84% | Buy |
| AQSTAquestive Therapeutics Inc. Common Stock | $599.9M | $44.5M | -188.09% | -$0.78 | -4.21% | Buy |
| EVOEvotec SE American Depositary Shares | $614.8M | — | — | -$0.29 | -2.26% | Hold |